Immunogenicity in Biopharmaceuticals
Received Date: Apr 01, 2024 / Accepted Date: Apr 30, 2024 / Published Date: Apr 30, 2024
Abstract
In the realm of biopharmaceuticals, ensuring therapeutic efficacy and safety is paramount. However, the immune system's response to these complex therapeutic agents, known as immunogenicity, poses a significant challenge. In this article, we delve into the intricacies of immunogenicity, exploring its causes, consequences, and strategies for mitigation in the development and administration of biopharmaceuticals.
Citation: Louise R (2024) Immunogenicity in Biopharmaceuticals. Clin PharmacolBiopharm, 13: 443.
Copyright: © 2024 Louise R. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 342
- [From(publication date): 0-2024 - Dec 31, 2024]
- Breakdown by view type
- HTML page views: 301
- PDF downloads: 41
